Dai ichi Life Insurance Company Ltd Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Dai ichi Life Insurance Company Ltd boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 15.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 128,109 shares of the healthcare conglomerate’s stock after acquiring an additional 17,108 shares during the period. UnitedHealth Group accounts for approximately 1.4% of Dai ichi Life Insurance Company Ltd’s portfolio, making the stock its 9th largest holding. Dai ichi Life Insurance Company Ltd’s holdings in UnitedHealth Group were worth $67,446,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC grew its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. Finally, O Brien Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 36.8% during the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after buying an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Finally, Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 1.2 %

Shares of UNH traded up $6.32 during mid-day trading on Tuesday, reaching $523.55. 2,311,078 shares of the company’s stock traded hands, compared to its average volume of 4,206,285. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $481.87 billion, a P/E ratio of 31.79, a P/E/G ratio of 1.52 and a beta of 0.55. The stock’s 50-day moving average is $486.97 and its two-hundred day moving average is $511.04. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.26 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.